|
Market Closed -
Nasdaq
00:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 14.00 USD | -2.85% |
|
-14.32% | - |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-20 | Drug developer Lycia Therapeutics targets $938 million valuation in US IPO | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.05% | -12.93% | - | - | - | - | - | - | - | 683M | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +0.33% | -7.32% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.57B | |
| +0.16% | +1.73% | +8.83% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -0.76% | +1.68% | +0.51% | +27.74% | +20.83% | +25.26% | +51.36% | +7.11% | +277.75% | 45.03B | |
| -1.32% | -4.72% | -0.17% | +12.42% | +20.59% | +16.15% | +114.94% | -0.25% | +1,016.64% | 42.17B | |
| +1.28% | -5.27% | -7.71% | -1.00% | +133.75% | +221.06% | +900.46% | +574.83% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +15.18% | +30.19% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| +0.21% | -4.42% | -12.05% | -4.34% | -8.47% | -17.83% | -4.45% | -68.74% | - | 21.82B | |
| +1.79% | -0.73% | -19.29% | -9.32% | -45.43% | -42.10% | +297.70% | +259.73% | +590.19% | 20.38B | |
| -0.48% | +8.21% | +9.35% | +14.28% | +19.92% | +12.92% | +169.11% | +219.81% | +2,243.49% | 18.93B | |
| +0.42% | +13.11% | +21.12% | +59.07% | +78.87% | +82.71% | +106.73% | -17.04% | +366.53% | 17.06B | |
| -0.58% | +8.20% | +8.59% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| +0.35% | +1.63% | +12.11% | +17.25% | +49.30% | +63.64% | +223.96% | +207.23% | +499.27% | 16.13B | |
| +0.32% | +5.00% | +6.95% | -2.91% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.44% | +4.77% | +3.95% | +8.13% | +0.16% | +0.26% | -22.44% | -35.22% | +126.77% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | -0.53% | +3.29% | +1.73% | +12.92% | +38.10% | +40.07% | +175.12% | +158.70% | +925.87% | 27.73B | |
| Weighted average by Cap. | -0.51% | +2.91% | -0.07% | +12.70% | +36.68% | +39.32% | +164.19% | +122.88% | +1,234.34% |
- Stock Market
- Stocks
- IAM Stock
- Sector Iambic Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
